St. Mary’s Health and Clearwater Valley Health Acquire Arnzen Super Drug

In a significant move aimed at enhancing healthcare services in north-central Idaho, St. Mary’s Health and Clearwater Valley Health have jointly announced the acquisition of Arnzen Super Drug Inc., which includes its pharmacy locations in Cottonwood, Kamiah, and Orofino. The purchase marks the continuation of a legacy that has served the community for over 135 years.

Continuing a Legacy of Service

Founded in 1890, Arnzen Super Drug has become a staple in the region, providing essential pharmacy care and building a reputation for community-focused service. The acquisition will enable St. Mary’s Health and Clearwater Valley Health to uphold and enhance this legacy. Rod Arnzen, who has been instrumental in the company’s success, expressed his enthusiasm for the transition, stating, “I am so excited to see the Arnzen legacy continue forward with Kootenai Health, St. Mary’s Health, and Clearwater Valley Health. It ensures my patients will receive the exceptional local care and continued service from my staff that they’ve relied on for so many years — and for many more years to come.”

Lenne Bonner, CEO of both St. Mary’s Health and Clearwater Valley Health, emphasized the importance of this acquisition, saying, “We are incredibly grateful for the foundation that Arnzen’s has established over the past 135 years. Arnzen and his staff have served this region with integrity and dedication.” Bonner added that the commitment to “honor what Arnzen’s has built” involves supporting dedicated staff and investing in the future of local pharmacy services.

Plans for Future Development

The pharmacies will continue to operate with their existing staff, ensuring the same personalized service that patients have come to trust. As the transition unfolds, St. Mary’s Health and Clearwater Valley Health plan to invest in expanded resources and enhanced coordination of care. This includes maintaining uninterrupted service for patients, with no disruptions anticipated during the transition period.

Bonner reiterated the organizations’ commitment to strengthening pharmacy services in the area, stating, “Our commitment is simple: to honor what Arnzen’s has built, to support the dedicated staff who have served so faithfully, and to invest in the future.” More information regarding the acquisition and its implications for the community will be shared as the process progresses.

This acquisition not only represents a continuation of Arnzen Super Drug’s historical service but also signals a proactive approach to improving healthcare accessibility in Idaho’s rural communities. With ongoing support from St. Mary’s Health and Clearwater Valley Health, the future of pharmacy care in the region looks promising.